Although it was initially aimed at treating cancer, HDAC inhibition was later shown to have potential in the treatment of neurodegenerative diseases such as Alzheimer’s disease (AD), Huntington’s disease (HD), Parkinson’s disease (PD), and multiple sclerosis [57,58,59,60,61]. The gene discussed is HDAC9; the disease is cancer.